Evidence map›Paper›PMID 29508945›Full record

ArticleJournal of the International AIDS Society2018

A tale of two countries: progress towards UNAIDS 90-90-90 targets in Botswana and Australia.

Tafireyi Marukutira, Mark Stoové, Shahin Lockman, Lisa A Mills, Tendani Gaolathe, Refeletswe Lebelonyane, Joseph N Jarvis, Sherrie L Kelly, David P Wilson, Stanley Luchters and 2 more

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Observational
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Causal Structural Learning on MPHIA Individual Dataset.Journal of the American Statistical Association · 2022
    Article
  11. Article
  12. Progress towards 2020 global HIV impact and treatment targets.Journal of the International AIDS Society · 2021
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Treatment as Prevention: Concepts and Challenges for Reducing HIV Incidence.Journal of acquired immune deficiency syndromes (1999) · 2019
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tafireyi MarukutiraPublic Health, Burnet Institute, Melbourne, Vic., Australia.ORCID 0000-0003-1142-6114
Mark StoovéPublic Health, Burnet Institute, Melbourne, Vic., Australia.
Shahin LockmanDivision of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA.
Lisa A MillsDivision of Global Health, Centers for Disease Control and Prevention, Gaborone, Botswana.
Tendani GaolatheDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Refeletswe LebelonyaneDepartment of HIV Prevention and Care, Ministry of Health, Gaborone, Botswana.
Joseph N JarvisBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Sherrie L KellyInfectious Diseases Modelling, Burnet Institute, Melbourne, Vic., Australia.
David P WilsonInfectious Diseases Modelling, Burnet Institute, Melbourne, Vic., Australia.
Stanley LuchtersPublic Health, Burnet Institute, Melbourne, Vic., Australia.
Suzanne M CrowePublic Health, Burnet Institute, Melbourne, Vic., Australia.
Margaret HellardDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia.

Funding

Mentoring in Patient-Oriented HIV Research in the Era of Universal ARTK24AI131928 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI SHAHIN LOCKMAN · 2017 to 2026
$1.9M
CGH CDC HHS U2G GH001911NIAID NIH HHS K24 AI131928
6 · The paper itself

Abstract

UNAIDS 90-90-90 targets and Fast-Track commitments are presented as precursors to ending the AIDS epidemic by 2030, through effecting a 90% reduction in new HIV infections and AIDS-related deaths from 2010 levels (HIV epidemic control). Botswana, a low to middle-income country with the third-highest HIV prevalence, and Australia, a low-prevalence high-income country with an epidemic concentrated among men who have sex with men (MSM), have made significant strides towards achieving the UNAIDS 90-90-90 targets. These two countries provide lessons for different epidemic settings. This paper discusses the lessons that can be drawn from Botswana and Australia with respect to their success in HIV testing, treatment, viral suppression and other HIV prevention strategies for HIV epidemic control. Botswana and Australia are on target to achieving the 90-90-90 targets for HIV epidemic control, made possible by comprehensive HIV testing and treatment programmes in the two countries. As of 2015, 70% of all people assumed to be living with HIV had viral suppression in Botswana and Australia. However, HIV incidence remains above one per cent in the general population in Botswana and in MSM in Australia. The two countries have demonstrated that rapid HIV testing that is accessible and targeted at key and vulnerable populations is required in order to continue identifying new HIV infections. All citizens living with HIV in both countries are eligible for antiretroviral therapy (ART) and viral load monitoring through government-funded programmes. Notwithstanding their success in reducing HIV transmission to date, programmes in both countries must continue to be supported at current levels to maintain epidemic suppression. Scaled HIV testing, linkage to care, universal ART, monitoring patients on treatment over and above strengthened HIV prevention strategies (e.g. male circumcision and pre-exposure prophylaxis) will all continue to require funding. The progress that Botswana and Australia have made towards meeting the 90-90-90 targets is commendable. However, in order to reduce HIV incidence significantly towards 2030, there is a need for sustained HIV testing, linkage to care and high treatment coverage. Botswana and Australia provide useful lessons for developing countries with generalized epidemics and high-income countries with concentrated epidemics.

Indexed as

AustraliaBotswanaEpidemicsFemaleHIV InfectionsHumansMalePre-Exposure ProphylaxisViral Load90-90-90 targetsARVAustraliaBotswanaHIV care continuumHIV testingviral suppression

Identifiers

PMID29508945
PMCPMC5838412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.